271 GFP-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous non-metal compounds | 20 | 7.6 | 2.62× | q < 0.0001 | |
| Homogeneous metal compounds | 16 | 17.4 | 0.92× | q = 0.80 | |
| Organic oxygen compounds | 4 | 7.1 | 0.57× | q = 0.36 | |
| Organoheterocyclic compounds | 2 | 5.5 | 0.37× | q = 0.22 | |
| Organic acids and derivatives | 2 | 5.5 | 0.36× | q = 0.22 | |
| Nucleosides, nucleotides, and analogues | 0 | 9.8 | 0 | q < 0.0001 | |
| Organometallic compounds | 1 | 0.1 | 20× | not tested | |
| Organosulfur compounds | 4 | 0.7 | 5.48× | not tested | |
| Organic nitrogen compounds | 2 | 1.1 | 1.77× | not tested | |
| Benzenoids | 1 | 2.6 | 0.39× | not tested | |
| Lipids and lipid-like molecules | 1 | 4.0 | 0.25× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03345 | BME | Mercaptoethanol | 8 |
| DB11145 | HQY | Oxyquinoline | 8 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 5 |
| DB09157 | CO2 | Carbon dioxide | 5 |
| DB02175 | MLA | Malonic acid | 3 |
| DB18267 | HEM | Ferroheme | 3 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 2 |
| DB03309 | NHE | N-cyclohexyltaurine | 2 |
| DB03412 | LDO | 6-hydroxynorleucine | 1 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 1 |
| DB07344 | AE4 | 3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL | 1 |
| DB09140 | OXY | Oxygen | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 133 |
| MGmetal | MAGNESIUM ION | 66 |
| NAmetal | SODIUM ION | 62 |
| CUmetal | COPPER (II) ION | 46 |
| SO3 | SULFITE ION | 33 |
| IOD | IODIDE ION | 24 |
| NImetal | NICKEL (II) ION | 22 |
| CAmetal | CALCIUM ION | 21 |
| ZNmetal | ZINC ION | 19 |
| Kmetal | POTASSIUM ION | 18 |
| BME | BETA-MERCAPTOETHANOL | 14 |
| COmetal | COBALT (II) ION | 12 |
| CSmetal | CESIUM ION | 8 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 8 |
| HQY | quinolin-8-ol | 8 |
| SPD | SPERMIDINE | 8 |
| BR | BROMIDE ION | 7 |
| UNL | Unknown ligand | 7 |
| DB5 | [(4~{S})-4,5,6,7,8,9-hexahydro-1~{H}-cycloocta[d][1,2,3]triazol-4-yl] hydrogen carbonate | 6 |
| CO2 | CARBON DIOXIDE | 5 |